{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:32:33Z","timestamp":1761489153554},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T00:00:00Z","timestamp":1369872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2288-13-68","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T17:02:09Z","timestamp":1369933329000},"source":"Crossref","is-referenced-by-count":2,"title":["Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"13","author":[{"given":"Sumit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D","family":"Pole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Guttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ejca.2007.05.014","volume":"43","author":"LF Ellison","year":"2007","unstructured":"Ellison LF, Pogany L, Mery LS: Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Eur J Cancer. 2007, 43: 1967-1975. 10.1016\/j.ejca.2007.05.014.","journal-title":"Eur J Cancer"},{"key":"945_CR2","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1200\/JCO.2011.40.8617","volume":"30","author":"C-H Pui","year":"2012","unstructured":"Pui C-H, Pei D, Pappo AS, Howard SC, Cheng C, Sandlund JT, Furman WL, Ribeiro RC, Spunt SL, Rubnitz JE, et al: Treatment outcomes in black and white children with cancer: results from the SEER database and St. Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol. 2012, 30: 2005-2012. 10.1200\/JCO.2011.40.8617.","journal-title":"J Clin Oncol"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","volume":"28","author":"MA Smith","year":"2010","unstructured":"Smith MA, Seibel NL, Altekruse SF, Ries LAG, Melbert DL, O'Leary M, Smith FO, Reaman GH: Outcomes for children and adolescents with cancer: Challenges for the twenty-first century. J Clin Oncol. 2010, 28: 2625-2634. 10.1200\/JCO.2009.27.0421.","journal-title":"J Clin Oncol"},{"key":"945_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL: Improved survivial for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children's Oncology Group. J Clin Oncol. 2012, 30: 1663-1669. 10.1200\/JCO.2011.37.8018.","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"945_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/pds.3241","volume":"21","author":"R Aplenc","year":"2012","unstructured":"Aplenc R, Fisher BT, Huang YS, Li Y, Alonzo TA, Gerbing RB, Hall M, Bertoch D, Keren R, Seif AE, et al: Merging of the national cancer institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparitive effectiveness research: a report from the Children's oncology group. Pharmacoepidemiol Drug Saf. 2012, 21 (Suppl 2): 37-43.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"945_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/pbc.24270","volume":"60","author":"DM Walker","year":"2012","unstructured":"Walker DM, Fisher BT, Seif AE, Huang YS, Torp K, Li Y, Aplenc R: Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the pediatric health information systems database. Pediatr Blood Cancer. 2012, 60 (4): 616-620.","journal-title":"Pediatr Blood Cancer"},{"issue":"13","key":"945_CR7","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.2001.19.13.3173","volume":"19","author":"TR Moller","year":"2001","unstructured":"Moller TR, Garwicz S, Barlow L, Winther JF, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, et al: Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic Countries. J Clin Oncol. 2001, 19 (13): 3173-3181.","journal-title":"J Clin Oncol"},{"issue":"4","key":"945_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/pbc.22601","volume":"55","author":"BT Fisher","year":"2010","unstructured":"Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R: Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study. Pediatr Blood Cancer. 2010, 55 (4): 655-661. 10.1002\/pbc.22601.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"945_CR9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bjc.6602085","volume":"91","author":"SV Koch","year":"2004","unstructured":"Koch SV, Kejs AMT, Engholm G, Johansen C, Schmiegelow K: Educational attainment among survivors of childhood cancer: A population-based cohort study in Denmark. Br J Cancer. 2004, 91 (5): 923-928.","journal-title":"Br J Cancer"},{"key":"945_CR10","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","volume":"360","author":"CH Pui","year":"2009","unstructured":"Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009, 360: 2730-2741. 10.1056\/NEJMoa0900386.","journal-title":"N Engl J Med"},{"key":"945_CR11","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM: Recent advances in neuroblastoma. N Engl J Med. 2010, 362: 2202-2211. 10.1056\/NEJMra0804577.","journal-title":"N Engl J Med"},{"key":"945_CR12","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1002\/cncr.27552","volume":"118","author":"AM Meyer","year":"2012","unstructured":"Meyer AM, Carpenter WR, Abernethy AP, Sturmer T, Kosorok MR: Data for cancer comparative effectiveness research: Past, present, and future potential. Cancer. 2012, 118: 5186-5197. 10.1002\/cncr.27552.","journal-title":"Cancer"},{"issue":"6","key":"945_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","volume":"11","author":"JE Rubnitz","year":"2010","unstructured":"Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, Pounds S, Razzouk BI, Lacayo NJ, Cao X, et al: Minimal residual disease-directed therapy for childhood acute myeloid leukemia: Results of the AML02 multicenter trial. Lancet Oncol. 2010, 11 (6): 543-552. 10.1016\/S1470-2045(10)70090-5.","journal-title":"Lancet Oncol"},{"issue":"1","key":"945_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ijc.11004","volume":"105","author":"ML Greenberg","year":"2003","unstructured":"Greenberg ML, Barr RD, DiMonte B, McLaughlin E, Greenberg C: Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003, 105 (1): 88-91. 10.1002\/ijc.11004.","journal-title":"Int J Cancer"},{"issue":"31","key":"945_CR15","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","volume":"28","author":"M Arico","year":"2010","unstructured":"Arico M, Schrappe M, Hunger SP, Carroll WL, Conter V, Galimberti S, Manabe A, Saha V, Baruchel A, Vettenranta K, et al: Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol. 2010, 28 (31): 4755-4761. 10.1200\/JCO.2010.30.1325.","journal-title":"J Clin Oncol"},{"issue":"12","key":"945_CR16","first-page":"4036","volume":"94","author":"NA Heerema","year":"1999","unstructured":"Heerema NA, Nachman JB, Sather HN, Sensel MG, Lee MK, Hutchinson R, Lange BJ, Steinherz PG, Bostrom B, Gaynon PS, et al: Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood. 1999, 94 (12): 4036-4045.","journal-title":"Blood"},{"key":"945_CR17","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","volume":"111","author":"MJ Borowitz","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll A, Carroll WL, Linda S, Martin PL, Pullen J, Viswanatha D, et al: Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a children's oncology group study. Blood. 2008, 111: 5477-5485. 10.1182\/blood-2008-01-132837.","journal-title":"Blood"},{"issue":"12","key":"945_CR18","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1038\/sj.leu.2401977","volume":"14","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Camitta B, Pui CH: Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia. 2000, 14 (12): 2193-2194. 10.1038\/sj.leu.2401977.","journal-title":"Leukemia"},{"issue":"1","key":"945_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"R Landis","year":"1977","unstructured":"Landis R, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33 (1): 159-174. 10.2307\/2529310.","journal-title":"Biometrics"},{"key":"945_CR20","volume-title":"Statistical methods for rates and proportions","author":"JL Fleiss","year":"1981","unstructured":"Fleiss JL: Statistical methods for rates and proportions. 1981, New York: John Wiley, 2","edition":"2"},{"issue":"1","key":"945_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/asheducation-2010.1.7","volume":"2010","author":"D Campana","year":"2010","unstructured":"Campana D: Minimal residual disease in acute lymphoblastic leukemia. Hematology. 2010, 2010 (1): 7-12. 10.1182\/asheducation-2010.1.7.","journal-title":"Hematology"},{"issue":"15","key":"945_CR22","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","volume":"119","author":"I-M Chen","year":"2012","unstructured":"Chen I-M, Harvey RC, Mullighan CG, Gastier-Foster F, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, et al: Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a children's oncology group. Blood. 2012, 119 (15): 3512-3522. 10.1182\/blood-2011-11-394221.","journal-title":"Blood"},{"issue":"6","key":"945_CR23","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BES, Kinsey SE, Eden TOB, Vora AJ, Mitchell CD, Harrison CJ: Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood. 2007, 109 (6): 2327-2330. 10.1182\/blood-2006-08-040436.","journal-title":"Blood"},{"issue":"8","key":"945_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/1097-0142(19850415)55:8<1637::AID-CNCR2820550804>3.0.CO;2-H","volume":"55","author":"T Revesz","year":"1985","unstructured":"Revesz T, Kardos G, Kajtar P, Schuler D: The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia. Cancer. 1985, 55 (8): 1637-1640. 10.1002\/1097-0142(19850415)55:8<1637::AID-CNCR2820550804>3.0.CO;2-H.","journal-title":"Cancer"},{"issue":"18","key":"945_CR25","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1016\/j.ejca.2010.07.001","volume":"46","author":"M Bonilla","year":"2010","unstructured":"Bonilla M, Gupta S, Vasquez R, Fuentes SL, DeReyes G, Ribeiro KCB, Sung L: Predictors of outcome and methodological issues in children with acute lymphoblastic leukemia in El Salvador. Eur J Cancer. 2010, 46 (18): 3280-3286. 10.1016\/j.ejca.2010.07.001.","journal-title":"Eur J Cancer"},{"issue":"5","key":"945_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.mayocp.2012.01.015","volume":"87","author":"CA Arndt","year":"2012","unstructured":"Arndt CA, Rose PS, Folpe AL, Laack NN: Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012, 87 (5): 475-487. 10.1016\/j.mayocp.2012.01.015.","journal-title":"Mayo Clin Proc"},{"key":"945_CR27","volume-title":"Med Care","author":"BT Fisher","year":"2012","unstructured":"Fisher BT, Harris T, Torp K, Seif AE, Shah A, Huang YS, Bailey LC, Kersun LS, Reilly AF, Rheingold SR, et al: Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data. Med Care. 2012, [Epub ahead of print]"},{"issue":"Suppl","key":"945_CR28","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/cncr.22102","volume":"7","author":"A Bleyer","year":"2006","unstructured":"Bleyer A, Budd T, Montello M: Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006, 7 (Suppl): 1645-1655.","journal-title":"Cancer"},{"key":"945_CR29","first-page":"114","volume":"23","author":"A Bleyer","year":"1996","unstructured":"Bleyer A: The adolescent gap in cancer treatment. J Regist Manage. 1996, 23: 114-115.","journal-title":"J Regist Manage"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2288-13-68\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-13-68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:31:53Z","timestamp":1548099113000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-13-68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/1471-2288-13-68","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]},"article-number":"68"}}